Protective effect of melatonin on blood⁃brain barrier dysfunction in rats with chronic cerebral hypoperfusion

Shao⁃peng WANG, Ru WANG, Dan⁃dan LI, Hong⁃yi ZHAO, Li⁃yi CHI, Yong⁃hua HUANG

Abstract


Objective To investigate the mechanism of the effect of melatonin (MT) on permeability of blood-brainbarrier (BBB) in chronic cerebral hypoperfusion (CCH) rats. Methods Therat model of CCH was established by bilateral common carotid artery occlusion (BCCAO). A total of 72 male Sprague-Dawley rats were randomly divided into 4 groups:sham group (N=18), BCCAO group (N=18), the melatonin [5 mg/(kg·d)] treatment model group (MT1 group, N=18), and the melatonin [10 mg/(kg·d)] treatment model group (MT2 group, N=18). Evans blue staining and fluorescein-labeled glucoside (FITC-Dextran) staining marked by fluorescein isothiocyanate (FITC) were used to assess the permeability o fBBB in rats. Expression of matrix metalloproteinase-2 (MMP-2) and MMP-9 mRNA levels in basal ganglia of the brain were measured by quantitative real-time polymerase chain reaction (qRT-PCR). Expression of Occludin and Claudin-5 protein in rat basal ganglia were measured by Western blotting method. Results Compared with the sham group, the fluorescence density in basal ganglia was increased (P = 0.000), expression of MMP-2 and MMP-9 were increased (all P=0.000),and expression of Occludin and Claudin-5 were decreased (all P =0.000) of BCCAO group. Compared with the BCCAO group, the fluorescence density in basal ganglia was decreased (P=0.021), the expression of MMP-2 was decreased (P=0.000) and the expression of Claudin-5 was increased (P=0.000) in MT1 group, and the differences with sham group were statistically significant (P=0.000, 0.006, 0.000). Compared with the BCCAO group, in MT2 group,the fluorescence degree in basal ganglia was further decreased (P=0.000), the expression of MMP-2 and MMP-9 were decreased (all P=0.000),and were similar to the sham group (all P>0.05), while expression of Occludin and Claudin-5 were increased (all P=0.000) but lower than those of sham group (P=0.003, 0.000). Compared with the two melatonin treatment groups, the efficacy of the 10mg/(kg·d) group (MT2 group) was better thanthat of the 5mg/(kg·d ) group (MT1 group, all P<0.05). Conclusions Melatonin may protect the integrity of BBB by inhibiting the degradation of Occludin and Claudin-5 protein through inhibiting the expression of matrix metalloproteinases.

DOI:10.3969/j.issn.1672⁃6731.2019.08.004


Keywords


Cerebral small vessel diseases; Melatonin; Blood⁃brain barrier; Disease models, animal

Full Text: PDF

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.